Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.

Pogrebniak A, Schemainda I, Azzam K, Pelka-Fleischer R, Nüssler V, Hasmann M.

Eur J Med Res. 2006 Aug 30;11(8):313-21.

PMID:
17052966
2.

Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.

Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, Schemainda I, Hasmann M, Saltz LB, Koutcher JA.

Clin Cancer Res. 2005 May 1;11(9):3503-13.

4.

Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.

Pogrebniak A, Schemainda I, Pelka-Fleischer R, Nüssler V, Hasmann M.

Eur J Med Res. 2003 Oct 22;8(10):438-50.

PMID:
14594650
5.

Cytoprotective features of selenazofurin in hematopoietic cells.

Pogrebniak A, Hasmann M, Schemainda I, Pelka-Fleischer R, Nuessler V.

Int J Clin Pharmacol Ther. 2002 Aug;40(8):368-75.

PMID:
12467305
6.

Supplemental Content

Loading ...
Support Center